%0 Journal Article %A Melanie Nana %A Catherine Nelson-Piercy %T COVID-19 in pregnancy %D 2021 %R 10.7861/clinmed.2021-0503 %J Clinical Medicine %P e446-e450 %V 21 %N 5 %X Pregnant women with COVID-19 are less likely to be symptomatic than non-pregnant counterparts. Risk factors for severe disease include being overweight or obese, greater than 35 years old, and having pre-existing comorbidities. Those who develop severe disease have increased rates of admission to an intensive care unit, requiring invasive ventilation and pre-term birth.Pregnant and breastfeeding women with COVID-19 should be investigated as of outside pregnancy and should receive proven therapies (such as corticosteroids and tocilizumab) on a risk/benefit basis. Admitted women should receive multidisciplinary care with input from senior decision makers and early escalation where required. There are no safety concerns ­surrounding the COVID-19 vaccination and fertility or pregnancy, and so it should be offered to women based on their age and clinical risk group, in line with non-pregnant women. %U https://www.rcpjournals.org/content/clinmedicine/21/5/e446.full.pdf